J Mass Spectrom Adv Clin Lab. 2022 Jan;23
50-57
Introduction: Differential mobility separation (DMS) is an analytical technique used for rapid separation of ions and isomers based on gas phase mobility prior to entering a mass spectrometer for analysis. The entire DMS process is accomplished in fewer than 20 ms and can be used as a rapid alternative to chromatographic separation.Objective: The primary objective was to evaluate the utility of DMS-tandem mass spectrometry (DMS-MS/MS) as a replacement for immunoassay-based clinical toxicology testing.
Methods: A sensitive DMS-MS/MS method was developed and validated for simultaneous identification of 33 drugs and metabolites in human urine samples. After DMS optimization, the method was validated and used to screen 56 clinical urine samples. These results were compared to results obtained by immunoassay.
Results: The DMS-MS/MS method achieved limits of detection ranging from 5 to 100 ng/mL. Moreover, the total analysis time was 2 min per sample. For the method performance evaluation, DMS-MS/MS results were compared with previously obtained urine toxicology immunoassay results. DMS-MS/MS showed higher sensitivity and identified 20% more drugs in urine, which were confirmed by LC-MS/MS.
Conclusion: The DMS-MS/MS as applied in our lab demonstrated the capability for rapid drug screening and provided better analytical performance than immunoassay.
Keywords: 6-MAM, 6-Monoacetylmorphine; AMPH, amphetamines/ecstasy; BENZ, benzodiazepines; BUPR, buprenorphine; CE, Collision energy; COV, compensation voltage; CXP, collision cell exit potential; DAPPI, atmospheric pressure photo ionization; DART, direct analysis in real time; DC, direct current; DESI, desorption electrospray ionization; DMO, DMS offse; DMS, differential mobility separation; DP, declustering potential; DR, DMS resolution enhancement; DT, DMS cell temperature; Differential mobility separation; Drugs of abuse; EDDP, 2-ethylidene1,5-dimethyl-3,3-diphenylpyrrolidine; EP, entrance potential; FAIMS, field asymmetric waveform ion mobility spectrometry; FSI, fiber spray ionization; GC-MS or LC-MS, gas chromatography- or liquid chromatography-mass spectrometry; GS1, ion source gas 1; GS2, ion source gas 2; IMS, ion mobility spectrometry, IS, internal standards, LOD, limit of detection, MD, modifier, MDC, modifier composition, ME, matrix effects; MRM, multiple reaction monitoring; MS/MS, tandem mass spectrometry; Mass spectrometry; OPI, opiates; OXY, oxycodone/oxmorphone; QCs, quality controls; SRM, selected reaction monitoring; SV, separation voltage; Urine drug screening; WT-ESI, wooden-tip electrospray ionization